Besivance Suspension
Product Images NDC 82260-466

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Besivance (NDC 82260-466). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Americas Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (964c5a85 3cc2 4d53 Ab7d F8d205d997e4 01)

Chem Structure (964c5a85 3cc2 4d53 Ab7d F8d205d997e4 01)
Chemical structure of Besifloxacin hydrochloride showing its molecular formula C19H21ClFN3O3·HCl and a molecular weight of 430.30.*
FDA Label Image

Carton (Carton)

Carton (Carton)
Packaging label for Besivance Besifloxacin Ophthalmic Suspension 0.6%, sterile, in a 5 mL bottle by Bausch & Lomb Americas Inc. The label includes dosage information, storage instructions, active ingredient strength (6 mg/mL), inactives, preservative content, and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.